What is the significance of a grade 2 placenta on ultrasound at 32 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Grade 2 Placenta at 32 Weeks: Clinical Significance

A grade 2 placenta at 32 weeks gestation is a normal variant with no clinical significance and requires no additional evaluation or intervention. 1

Understanding Placental Grading

The Grannum grading system classifies placental maturity from grade 0 (most immature) to grade III (most mature) based on ultrasound appearance of the basal plate, chorionic plate, and placental substance. 2 While historically this system was thought to correlate with fetal lung maturity and placental function, modern evidence demonstrates that placental grading does not reliably predict placental functional capacity or adverse pregnancy outcomes. 1

Evidence Against Clinical Utility

  • Placental grading at 31-34 weeks shows no correlation with actual placental function as measured by morphometric oxygen diffusive conductance, placental volume, or villous membrane characteristics. 1
  • This lack of correlation holds true even when excluding smokers or complicated pregnancies from analysis. 1
  • The original studies suggesting clinical significance of early placental maturation were conducted in the 1980s and have not been validated by contemporary research. 3, 2

When to Consider Further Evaluation

While the grade 2 placenta itself is not concerning, you should evaluate for actual clinical complications rather than relying on placental grade:

  • Assess for fetal growth restriction using estimated fetal weight and abdominal circumference measurements, defining FGR as below the 10th percentile. 4
  • Initiate umbilical artery Doppler surveillance if FGR is diagnosed, with weekly assessment recommended for decreased end-diastolic velocity or severe FGR (estimated fetal weight <3rd percentile). 4, 5
  • Screen for preeclampsia and hypertensive disorders, as these are present in 50-70% of early-onset FGR cases and represent the actual pathology, not the placental grade. 6

Common Pitfalls to Avoid

  • Do not use placental grading as a screening tool for placental insufficiency or to guide clinical management decisions. 1
  • Do not order additional testing, increase surveillance frequency, or alter delivery timing based solely on placental grade. 1
  • Focus instead on validated surveillance methods including serial growth ultrasounds, umbilical artery Doppler when FGR is diagnosed, and clinical assessment for maternal complications. 4, 5

Appropriate Management at 32 Weeks

Continue routine prenatal care with standard third-trimester surveillance:

  • Perform growth ultrasound if clinical suspicion exists for FGR (fundal height >3 cm less than gestational age). 5
  • If growth is normal and no other risk factors exist, no additional ultrasound surveillance is indicated based on placental grade alone. 5
  • Reserve intensive Doppler surveillance for pregnancies with confirmed FGR or other high-risk conditions, not for placental grading findings. 5, 7

References

Research

A reevaluation of placental grading and its clinical significance.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 1984

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Optimal Timing for Fetal Doppler Ultrasound in High-Risk Pregnancies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fetal Growth Restriction Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Biophysical Profile Initiation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.